Technology Listings


25 Results Sort By:
Extended Efficacy SARS-COV-2 Vaccine
­ Application A vaccine for SARS-COV-2 that can be used to protect against infection by future forms of Variant-of-Concern (VOC) or other SARS-like coronaviruses. Key Benefits An approach to developing a vaccine that would be effective against future mutations of SARS-COV-2. A vaccine that elicits an immune response to conserved portions...
Published: 5/13/2022       Contributor(s): Chinglai Yang, Ling Ye, Samuel Stampfer, Rui Jin
SARS-CoV-2 Subgenomic Replicon (SARS2-Rn)
­ Application A series of SARS-CoV-2 sub-genomic replicons as artificial bacterial chromosomes for the screening of SARS-CoV-2 in studies such as drug discovery and inhibitors assay. Key Benefits Can be used at a lower biosafety level than non-artificial copies of SARS-CoV-2. Can be used for high throughput screening and characterization...
Published: 4/19/2022       Contributor(s): Stefan Sarafianos, Shuiyun Lan
Yongshi: A Wild Boar Peptide with Anti-Viral Activity Targeting Covid-19
­ Application An antiviral cathelicidin peptide from wild boar that exhibits antiviral properties against SARS-CoV-2. Key Benefits Pan-coronavirus inhibitor that may be effective for all future variants. Functions as an inhibitor of ongoing infection. Early data suggests it is safe to use in human tissue. Market Summary Coronavirus disease...
Published: 4/19/2022       Contributor(s): Joshy Jacob, Mehul Suthar, Troy Von Beck, Nikita Mullick, Abigail Vanderheiden, Jeffrey Skolnick
Combination of Tetrahydrobiopterin and Arginine/ ± Arginase Inhibitors for the Treatment of COVID-19
­ Application A novel drug combination to address acute arginine/BH4 dysregulation that develops with COVID-19 and MIS-C infection. Key Benefits Potential to improve outcomes of those infected with COVID-19 with few side effects. Repurposing opportunity with the combination of two approved drugs (tetrahydrobiopterin and arginine). Addresses...
Published: 3/16/2022       Contributor(s): Claudia Morris, Louann Brown
Small Molecule Inhibitors for the Treatment of COVID-19 Infection
­ Application Small molecule therapy to treat patients infected with COVID-19 virus. Key Benefits Current FDA-approved therapeutic can be repurposed to fight COVID-19 infection. Treatment option for infected COVID-19 patients. Market Summary Coronavirus (COVID-19) is an infectious disease that causes severe acute respiratory syndrome coronavirus...
Published: 2/23/2022       Contributor(s): Jack Arbiser, Martijn van Hemert, Melissa Thaler
Bag-Valve-Mask (BVM) Ventilator
Application Simple, low-cost bag-valve-mask (ambu bag) ventilator for treating respiratory challenges associated with COVID-19 and acute respiratory distress syndrome. Key Benefits Enables ventilation of two patients simultaneously or allows alternating tidal volumes for a single patient. Simple, low-cost design. Technical Summary Georgia Tech,...
Published: 2/23/2022       Contributor(s): Susan Margulies, Shannon Yee, Michael Adams, Kentez Craig, Connor Hart, James Hurley, Jordan Kocher, Maxwell Praniewicz, Leon Williams, Christopher (Chris) Saldana
Serological Test for SARS-CoV-2
­ Application Clinical assay for detecting SARS-CoV-2 neutralizing antibodies. Key Benefits Highly specific and sensitive. Fewer false positives than commercially available tests. Market Summary SARS-CoV-2 is currently causing a devastating pandemic and there is a pressing need to understand the dynamics, specificity, and neutralizing...
Published: 1/24/2022       Contributor(s): Rafi Ahmed, Mehul Suthar, John Roback, Jens Wrammert, Robert Kauffman
Infection Control System for Resuscitation and Airway Management
Application Collapsible, single-use ‘pop-up tent’ system to prevent transmission of infectious disease during resuscitation and airway management. Key Benefits Provides protective barrier to prevent transmission of infectious disease. Allows adequate access to the patient for airway management procedures. Single-use to minimize infection...
Published: 9/15/2020       Contributor(s): Adam Klein, Russell Gore, David Wright
C19Check: COVID-19 Severity Stratification Tool
Application Algorithm for screening of individuals exhibiting coronavirus disease (COVID-19) symptoms. Key Benefits Allows mass screening of potential COVID-19 patients. Alleviates burden on hospitals and doctors’ offices. Reduces unnecessary interactions with individuals. May be used in regions with low internet access. Market Summary Coronavirus...
Published: 4/8/2020       Contributor(s): Justin Schrager, Alexander Isakov, David Wright, Anna Yaffee, Arthur Kellermann
Real-Time RT-PCR Assay for SARS-CoV-2
Application Triplex, internally-controlled real-time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Key Benefits Two viral targets to confirm detection in a single sample. Does not involve the performance of multiple reactions as are required for the majority of published assays. May be performed using several different...
Published: 4/8/2020       Contributor(s): Jesse Waggoner
1 2 3